29 Jun 2024
// PRESS RELEASE
18 Jan 2024
// PRESS RELEASE
15 Apr 2022
// PRESS RELEASE
Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.
About
CPhI South East AsiaCPhI South East Asia
Industry Trade Show
Not Confirmed
16-18 July, 2025
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Booth #8.0P75
28-30 October, 2025
Industry Trade Show
Booth #RH.G49
25-27 November, 2025
CONTACT DETAILS
Facebook: https://www.facebook.com/profile.php?id=100093970467910
Youtube: https://www.youtube.com/@BoaiNKY
Instagram: https://www.instagram.com/boainky/
Events
Webinars & Exhibitions
CPhI South East AsiaCPhI South East Asia
Industry Trade Show
Not Confirmed
16-18 July, 2025
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Booth #8.0P75
28-30 October, 2025
Industry Trade Show
Booth #RH.G49
25-27 November, 2025
https://www.pharmacompass.com/speak-pharma/we-owe-our-success-to-our-focus-on-r-d-quality-and-better-service
CORPORATE CONTENT #SupplierSpotlight
https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-seqens-evonik-make-strategic-moves-new-guidelines-deal-with-contamination
29 Jun 2024
// PRESS RELEASE
18 Jan 2024
// PRESS RELEASE
15 Apr 2022
// PRESS RELEASE
08 Apr 2019
// PRESS RELEASE
03 Apr 2019
// PRESS RELEASE
03 Apr 2019
// PRESS RELEASE
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40941
Submission : 2024-12-30
Status : Active
Type : II
Excipients
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36420
Submission : 2021-11-23
Status : Active
Type : IV
Excipients Web Link
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35341
Submission : 2020-12-24
Status : Active
Type : IV
Excipients Web Link
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37384
Submission : 2022-09-22
Status : Active
Type : IV
Excipients Web Link
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39370
Submission : 2024-01-22
Status : Active
Type : IV
Excipients Web Link
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36421
Submission : 2021-12-01
Status : Active
Type : IV
Excipients Web Link
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35501
Submission : 2021-02-05
Status : Active
Type : IV
Excipients Web Link
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36419
Submission : 2021-12-13
Status : Active
Type : IV
Excipients Web Link
Dosage Form : Cream / Lotion / Ointment, Solution
Grade : Topical
Application : Topical
Dosage Form : Capsule, Suspension, Tablet
Grade : Oral (Pharma Grade)
Application : Solubilizers
Excipient Details : KoVidone® K12 is used as a solubilizer & anti-crystallization agent in liquid products & matrix for amorphous solid dispersion via hot melt extrusion.
Pharmacopoeia Ref : USP/NF, EP, JP, KP, IP, BP
Technical Specs : NA
Ingredient(s) : Polyvinylpyrrolidone K12
Application : Fillers, Diluents & Binders
Excipient Details : KoVidone® K25 is used as a low viscosity wet binder in solid dosage forms such as capsules and tablets.
Pharmacopoeia Ref : USP/NF, EP, JP, KP, IP, BP
Technical Specs : NA
Ingredient(s) : Polyvinylpyrrolidone
Application : Fillers, Diluents & Binders
Excipient Details : KoVidone® K30 is used as a binder for tablets and capsules.
Pharmacopoeia Ref : USP/NF, EP, JP, KP, IP, BP
Technical Specs : NA
Ingredient(s) : Polyvinylpyrrolidone K30
Dosage Form : Capsule, Suspension, Tablet
Grade : Oral (Pharma Grade)
Application : Fillers, Diluents & Binders, Thickeners and Stabilizers
Excipient Details : KoVidone® K90 acts as a binder for tablets and capsules. It is also used as thickener and stabilizer in liquid dosage forms such as suspension.
Pharmacopoeia Ref : USP/NF, EP, JP, KP, IP, BP
Technical Specs : NA
Ingredient(s) : Polyvinylpyrrolidone K90
Dosage Form : Tablet
Grade : Oral (Pharma Grade)
Application : Direct Compression, Fillers, Diluents & Binders, Film Formers & Plasticizers
Excipient Details : KoVidone® Ultra VA64 is used as a tablet binder, direct compression binder, matrix former in amorphous solid dispersions, and film-forming polymer.
Pharmacopoeia Ref : USP/NF, EP, JP, KP, IP, BP
Technical Specs : NA
Ingredient(s) : Polyvinylpyrrolidone and Vinyl Acetate Copolymer
Dosage Form : Tablet
Grade : Oral (Pharma Grade)
Application : Direct Compression, Fillers, Diluents & Binders, Film Formers & Plasticizers
Excipient Details : KoVidone® VA64 is used as a binder in tablets, direct compression binder, matrix formers in amorphous solid dispersions, and film-forming polymer.
Pharmacopoeia Ref : USP/NF, EP, JP, KP, IP, BP
Technical Specs : NA
Ingredient(s) : Polyvinylpyrrolidone and Vinyl Acetate Copolymer
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Dosage Form : Gel
Grade : Oral
Application : Co-Processed Excipients, Controlled & Modified Release
Excipient Details : OraRez AN is a copolymer of methyl vinyl ether & maleic anhydride, used in topical products such as hydrogel and in controlled release of bioactives.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Methyl Vinyl Ether and Maleic Anhydride Copolymer
Application : Co-Processed Excipients
Excipient Details : OraRez® W is a copolymer of methyl vinyl ether and maleic acid, is an excellent bioadhesive, and is used in oral care products such as toothpaste.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Methyl Vinyl Ether and Maleic Acid Copolymer
Excipients by Ingredients
Excipients By applications
ABOUT THIS PAGE
Boai NKY Pharmaceuticals Ltd is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of Povidone Iodine bulk with DMF offered by Boai NKY Pharmaceuticals Ltd